Gene test could personalize stroke prevention for High-Risk patients

NCT ID NCT06714526

Recruiting now Disease control Sponsor: Sunnybrook Health Sciences Centre Source: ClinicalTrials.gov ↗

First seen Nov 20, 2025 · Last updated Apr 24, 2026 · Updated 22 times

Summary

This study looks at whether a simple genetic test can help doctors pick the right blood thinner for people who have had a stroke due to narrowed arteries in the brain. Some people's genes make the standard drug, clopidogrel, less effective. The study will compare the usual approach with a gene-guided approach that may use a different drug, ticagrelor. About 100 participants will be followed for 90 days to see if the gene-guided method is safe and practical.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL ATHEROSCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Dr. Mark I. Boulos - Sunnybrook Health Sciences Centre
RECRUITING

Toronto, Ontario, M4N3M5, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••
University of Calgary
NOT_YET_RECRUITING

Calgary, Alberta, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

INTRACRANIAL ATHEROSCLEROSIS